George Soros's DAWN Position Overview
George Soros (via Soros Fund Management LLC) currently holds 1.54 M shares of Day One Biopharmaceuticals, Inc. (DAWN) worth $33 M, representing 0.36% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in DAWN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Day One Biopharmaceuticals (DAWN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Day One Biopharmaceuticals (DAWN) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.54 M | New Buy | 1.54 M | $21.44 |
George Soros's Day One Biopharmaceuticals Investment FAQs
George Soros first purchased Day One Biopharmaceuticals, Inc. (DAWN) in Q1 2026, acquiring 1,539,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Day One Biopharmaceuticals, Inc. (DAWN) for 1 quarters since Q1 2026.
George Soros's largest addition to Day One Biopharmaceuticals, Inc. (DAWN) was in Q1 2026, adding 1,539,100 shares worth $33 M.
According to the latest 13F filing for Q1 2026, George Soros's firm, Soros Fund Management LLC, owns 1,539,100 shares of Day One Biopharmaceuticals, Inc. (DAWN), valued at approximately $33 M.
As of the Q1 2026 filing, Day One Biopharmaceuticals, Inc. (DAWN) represents approximately 0.36% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Day One Biopharmaceuticals, Inc. (DAWN) was 1,539,100 shares, as reported at the end of Q1 2026.